Social and Animal Welfare Features and Impacts
Dr. Pieters and her partners are working to characterize the detection of M. hyopneumoniae in processing fluids (PF), identify probable sources of the bacterium, and to evaluate the potential use of PF in M. hyopneumoniae monitoring and surveillance programs.
Dr. Vannucci and his partners are working to determine the impact of biosecurity procedures on the transmission and spread of Senecavirus A between pig populations.
Sinisa Vidovic and his team are working to develop a live, attenuated vaccine against critical outer membrane proteins (OMPs), which can prevent Salmonella colonization of chickens and turkeys.
Dr. Pieters and her partners are investigating the role of antimicrobial resistance on Mycoplasma eradication, to generate a PCR based test for M. hyopneumoniae selected antimicrobial susceptibility, and to evaluate the predictive value of the test in eradication success.
Krishona Martinson and her team are working to demonstrate equine carcass composting using affordable and readily available materials and Extension education with the aim of encouraging industry-wide adoption.
Sunil Kumar Mor and his team are studying the evolution and genomic constellations of newly re-emerging, lameness-associated turkey arthritis reoviruses (TARV) with a view to develop highly sensitive and specific diagnostic assays and to develop and evaluate safe and effective vaccines.
Abby Neu and her team are evaluating the delivery pathways for educational materials, workshops, and assistance for poultry producers related to biosecurity. By exploring the reliability of existing communication strategies they hope to discover gaps in communications and, ultimately, find new communications solutions.
Peter Larsen and his interdisciplinary team are working to develop a robust next-generation antemortem test for the rapid detection of Chronic wasting disease in biological samples secured from cervids (elk and white-tailed deer) using minimally invasive techniques.
Dr. Ly and his partners are working to develop and test a new vaccine for Hemorrhagic enteritis virus. The new vaccine will be based on viral vaccine vector (Pichinde virus, PICV) a technology recently developed by their laboratory.
Anup Johny has gathered an integrated, multi-college/department team to determine the efficacy of the combination of the dairy-originated probiotic, an industry vaccine, and two essential oils, against three emerging Salmonella serovars with potential to cause foodborne outbreaks, using applied microbiology, microbiome analysis, immunology, and genomics approaches.